Clinical trial
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With Endovascular Thrombectomy on Long-term Prognosis in Patients With Acute Ischemic Stroke (PPDET)
NCT04916197 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With Endovascular Thrombectomy on Long-term Prognosis in Patients With Acute Ischemic Stroke (PPDET)
- Lead sponsor
- Beijing Chao Yang Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 368 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke